These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7968913)

  • 21. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure.
    Achem AC; Achem SR; Stark ME; DeVault KR
    Am J Gastroenterol; 2003 Jan; 98(1):35-9. PubMed ID: 12526933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical application of esophageal manometry and 24-hour esophageal pH monitoring].
    Li H; Zhang Z; Wang T; Shang L; Li X
    Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):74-6. PubMed ID: 11829783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights in the pathophysiology of primary motility disorders of the esophagus.
    Janssens J; Sifrim D
    Verh K Acad Geneeskd Belg; 1997; 59(3):209-25; discussion 225-7. PubMed ID: 9490918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esophageal motility in low-grade reflux esophagitis, evaluated by stationary and 24-hour ambulatory manometry.
    Timmer R; Breumelhof R; Nadorp JH; Smout AJ
    Am J Gastroenterol; 1993 Jun; 88(6):837-41. PubMed ID: 8503376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of esophageal motility in response to bread swallows and water swallows.
    Johnston BT; Collins JS; McFarland RJ; Blackwell JN; Love AH
    Am J Gastroenterol; 1993 Mar; 88(3):351-5. PubMed ID: 8438839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double swallow.
    Postma GN; Burkhead LM; Moretz WH
    Ear Nose Throat J; 2006 Aug; 85(8):488. PubMed ID: 16999052
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reflux esophagitis: manometry and Ph measurement].
    Eberl T; Wienbeck M; Barnert J
    Praxis (Bern 1994); 1996 Nov; 85(45):1428-31. PubMed ID: 8975351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of distal esophageal impedance in individuals with and without esophageal motility abnormalities.
    Blonski W; Hila A; Vela MF; Castell DO
    J Clin Gastroenterol; 2008 Aug; 42(7):776-81. PubMed ID: 18360293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study.
    Grossi L; Spezzaferro M; Sacco LF; Marzio L
    Neurogastroenterol Motil; 2008 Jul; 20(7):760-6. PubMed ID: 18373654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of body position and food composition on esophageal motility in healthy probands].
    Wilhelm K; Frieling T; Enck P; Lübke HJ
    Z Gastroenterol; 1993 Sep; 31(9):475-9. PubMed ID: 8237086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Testing spasmolytic agents in man using esophageal manometry].
    Niemann H; Jakob G
    Arzneimittelforschung; 1971 Aug; 21(8):1217-20. PubMed ID: 5110023
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of floppy Nissen fundoplication on esophageal and gastric motility in gastroesophageal reflux.
    Vassilakis JS; Xynos E; Kasapidis P; Chrysos E; Mantides A; Nicolopoulos N
    Surg Gynecol Obstet; 1993 Dec; 177(6):608-16. PubMed ID: 8266274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study.
    Paterson WG; Wang H; Beck IT
    Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of esophageal peristalsis in preterm and term neonates.
    Staiano A; Boccia G; Salvia G; Zappulli D; Clouse RE
    Gastroenterology; 2007 May; 132(5):1718-25. PubMed ID: 17484869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Esophageal manometry findings in man following intravenous administration of a new cholinolytic agent HSp 2986, of atropine and scopolaminebutylbromide].
    Niemann H; Jakob G
    Arzneimittelforschung; 1971 Aug; 21(8):1220-1. PubMed ID: 5110024
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of orally administered scopolamine-butylbromide and HSp 2986. Esophageal manometric studies in man].
    Niemann H; Jakob G; Sievert R
    Arzneimittelforschung; 1972 Nov; 22(11):1944-6. PubMed ID: 4679070
    [No Abstract]   [Full Text] [Related]  

  • 37. [New aspects of the mechanism of action of molsidomine. Proceedings of a discussion by cardiology experts. Berlin, 15 April 1989].
    Med Klin (Munich); 1990 Feb; 85 Suppl 1():3-26. PubMed ID: 2333059
    [No Abstract]   [Full Text] [Related]  

  • 38. Current concepts on pathophysiology, diagnosis and treatment of diffuse oesophageal spasm.
    Storr M; Allescher HD; Classen M
    Drugs; 2001; 61(5):579-91. PubMed ID: 11368284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of molsidomine on esophageal motility in man].
    Allescher HD; Willis S; Stoschus B; Schusdziarra V; Classen M
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():71-2. PubMed ID: 7968913
    [No Abstract]   [Full Text] [Related]  

  • 40. Double blind placebo controlled study on the effect of the nitric oxide donor molsidomin and the 5-HT3 antagonist ondansetron on human esophageal motility.
    Willis S; Allescher HD; Stoschus B; Schusdziarra V; Classen M; Schumpelick V
    Z Gastroenterol; 1994 Nov; 32(11):632-6. PubMed ID: 7886971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.